GH Research to Attend Life Sciences Conference
Ticker: GHRS · Form: 6-K · Filed: Apr 10, 2024 · CIK: 1855129
Sentiment: neutral
Topics: investor-relations, conference
TL;DR
GH Research is meeting investors at a conference in Amsterdam next week.
AI Summary
GH Research PLC announced on April 10, 2024, that it will participate in Van Lanschot Kempen's Life Sciences Conference in Amsterdam from April 16-17, 2024. The company will hold one-on-one and small group investor meetings during the event.
Why It Matters
This conference provides GH Research an opportunity to engage with investors and potentially attract new capital or partnerships for its pharmaceutical development pipeline.
Risk Assessment
Risk Level: low — The filing is a routine announcement of participation in an investor conference, with no new financial or operational information disclosed.
Key Players & Entities
- GH Research PLC (company) — Registrant
- Van Lanschot Kempen (company) — Organizer of Life Sciences Conference
- April 16-17, 2024 (date) — Dates of the Life Sciences Conference
- Amsterdam (location) — Location of the Life Sciences Conference
FAQ
What is the purpose of GH Research PLC's participation in the Van Lanschot Kempen's Life Sciences Conference?
GH Research PLC will hold one-on-one and small group investor meetings during the conference.
When and where is the Van Lanschot Kempen's Life Sciences Conference taking place?
The conference is scheduled to take place in Amsterdam from April 16-17, 2024.
What type of report is GH Research PLC filing?
GH Research PLC is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the principal executive office address of GH Research PLC?
The principal executive office is located at Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.
Does GH Research PLC file annual reports under Form 20-F or 40-F?
GH Research PLC files annual reports under Form 20-F.
Filing Stats: 175 words · 1 min read · ~1 pages · Grade level 14.5 · Accepted 2024-04-10 07:07:39
Filing Documents
- ef20026495_6k.htm (6-K) — 7KB
- 0001140361-24-018998.txt ( ) — 8KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F GH Research PLC (the "Company") will hold one-on-one and small group investor meetings during the Van Lanschot Kempen's Life Sciences Conference, which is scheduled to take place in Amsterdam from April 16-17, 2024. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: April 10, 2024 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 2